| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |